NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 39 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -66.7% | 2,500 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $3,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $3,000 | -40.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $4,000 | -33.3% | 2,500 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $8,000 | +60.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $5,000 | 0.0% | 2,500 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $5,000 | 0.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | +50.0% |
Q2 2019 | $4,000 | -20.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $5,000 | +66.7% | 2,500 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $3,000 | -50.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | -40.0% |
Q2 2018 | $8,000 | -27.3% | 2,500 | 0.0% | 0.01% | -28.6% |
Q1 2018 | $11,000 | – | 2,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corrigan Financial, Inc. | 302,252 | $102,766 | 0.03% |
Virtu Financial LLC | 13,324 | $5 | 0.00% |
Bleakley Financial Group, LLC | 80,000 | $27,200 | 0.00% |
Beaird Harris Wealth Management, LLC | 24,400 | $8,296 | 0.00% |
One Day In July LLC | 10,000 | $3,400 | 0.00% |
Cubic Asset Management, LLC | 10,000 | $3,400 | 0.00% |
WMS Partners, LLC | 18,000 | $6,120 | 0.00% |
Simplicity Solutions, LLC | 80,000 | $27,200 | 0.00% |
WELLS FARGO & COMPANY/MN | 3,296 | $1,121 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |